16153-1-AP

antibody from Proteintech Group

Targeting: CCR2 CC-CKR-2, CD192, CKR2, CMKBR2, FLJ78302, MCP-1-R

Provider product page for 16153-1-AP

Western blot

ELISA

Immunohistochemistry

Flow cytometry

Antibody data

Antibody Data
Antigen structure
References [40]
Comments [0]
Validations
Western blot [1]
Immunohistochemistry [1]

Submit

Product number: 16153-1-AP - Provider product page
Provider: Proteintech Group
Proper citation: Proteintech Cat#16153-1-AP, RRID:AB_2262945
Product name: CCR2a-specific antibody
Antibody type: Polyclonal
Description: CCR2a-specific antibody (Cat. #16153-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: FC, IHC, WB,ELISA.
Reactivity: Human
Host: Rabbit
Conjugate: Unconjugated
Isotype: IgG
Vial size: 20ul, 150ul

CCR2 protein structure - 16153-1-AP shown in red.

Submitted references The USP1-WDR48 deubiquitinase complex functions as a molecular switch regulating tumor-associated macrophage activation and anti-tumor response.

Han D, Wang L, Jiang S, Su P, Chen B, Zhao W, Chen T, Zhang N, Wang X, Liang Y, Li Y, Li C, Chen X, Luo D, Yang Q
Cell death and differentiation 2026 Jan;33(1):92-110

Chlorogenic acid targets STING to alleviate pressure overload-induced heart failure and myocardial fibrosis.

Huang K, Xiao JL, Tang JY, Pu HY, Li FH, Gao K, Yu X, Guo SZ
Phytomedicine : international journal of phytotherapy and phytopharmacology 2026 Jan;150:157625

C-C motif receptor 2 is a core profibrotic factor in uremic cardiomyopathy.

Bao JF, Guo BC, Mo JJ, Zhu H, Jia N, Hou F, Liu Y, Li A
Disease models & mechanisms 2026 Jan 1;19(1)

Single-cell transcriptomic analysis reveals the association of Ccl6+Ccr2+Arg1+ macrophages with renal interstitial fibrosis in AKI.

Zheng X, Wang J, Chen W, Xu Q, Xu T, Chen L
PloS one 2025;20(9):e0332026

Protective effects of Shenkang injection against diabetic kidney disease via p38 MAPK/NFκB/MCP-1/CCR2 pathway inhibition.

Zhou X, Wang S, Jin G, Zhou K, Cai Y, Zhao Z
Frontiers in endocrinology 2025;16:1596000

LCN2 deficiency mitigates the neuroinflammatory damage following acute glaucoma.

Hu T, Meng S, Liu C, Fang W, Xia Z, Hu Y, Luo J, Xia X
Theranostics 2025;15(7):2967-2990

Structure-based design of orthosteric and allosteric CCR2 inhibitors for potential IPF therapy.

Yan G, Huang J, Huang Z, Luo S, Guo H, Tao S, Li E, Liu Y, Huang J, Liu Y, Liu Z, Zhao S, Chen J, Lei M
RSC advances 2025 Oct 28;15(49):41648-41666

Single-cell sequencing reveals a senescent immune landscape in bone marrow lesions inducing articular cartilage damage in osteoarthritis.

Lou P, Lu X, Li M, Yao Y, Shao X, Shou D, Fan X, Tong P, Zhang Y
Bone research 2025 Nov 21;13(1):94

Engineered Spirulina platensis for treating rheumatoid arthritis and restoring bone homeostasis.

Yang X, Rong K, Fu S, Yang Y, Liu S, Zhang C, Xu K, Zhang K, Zhu Y, Hao Y, Zhao J, Fu J
Nature communications 2025 May 13;16(1):4434

Cryo-trojan mesenchymal stem cells as non-living tumor-homing supercarriers for enhanced drug delivery and immune activation in prostate cancer.

Wang C, Rong X, Zhang F, Mu X, Jiang J
Materials today. Bio 2025 Jun;32:101650

Curcumin relieves CFA-induced inflammatory pain by inhibiting the AP-1/c-Jun-CCL2-CCR2 pathway in the spinal dorsal horn.

Zhu Y, Jiang Y, Lu X, Li S, Liu F, Xu Y, Tian Y, Gao L, Wei L
Molecular pain 2025 Jan-Dec;21:17448069251323668

Association between cytokines and progression-free survival in ovarian cancer following CRS/HIPEC treatment.

Chen CY, Wang TY, Liu JL, Ou YC, Lee LW, Hung CH, Lee CP, Lung J
Journal of ovarian research 2025 Jan 7;18(1):3

Phenotypic plasticity and increased infiltration of peripheral blood-derived TREM1(+) mono-macrophages following radiotherapy in rectal cancer.

Wang H, Zhai M, Li M, Han C, Liu L, Huang C, Zhao L, Yu D, Tao K, Ren J, Lin Z, Zhang T
Cell reports. Medicine 2025 Jan 21;6(1):101887

Cinobufagin modulates vasculogenic mimicry and tumor-associated macrophages to inhibit ovarian cancer progression.

Wang N, Yang Y, Wang H, Li Y, Wang M, Li Q
European journal of pharmacology 2025 Jan 15;987:177157

Engineered neutrophil membrane-camouflaged nanocomplexes for targeted siRNA delivery against myocardial ischemia reperfusion injury.

Jiang Y, Jiang R, Xia Z, Guo M, Fu Y, Wang X, Xie J
Journal of nanobiotechnology 2025 Feb 22;23(1):134

HDAC1-3 inhibition triggers NEDD4-mediated CCR2 downregulation and attenuates immunosuppression in myeloid-derived suppressor cells.

Xie Z, Shao J, Shen Z, Ye Z, Okada Y, Okuzaki D, Okada N, Tachibana M
Cancer immunology, immunotherapy : CII 2025 Feb 1;74(3):81

Interleukin-6 trans-signalling regulates monocyte chemoattractant protein-1 production in immune-mediated necrotizing myopathy.

Ma X, Gao HJ, Ge HZ, Zhang Q, Bu BT
Rheumatology (Oxford, England) 2025 Feb 1;64(2):849-859

Myeloid Deletion of Cdc42 Protects Liver From Hepatic Ischemia-Reperfusion Injury via Inhibiting Macrophage-Mediated Inflammation in Mice.

He J, Tang MY, Liu LX, Kong CX, Chen W, Wang L, Zhi SB, Sun HW, Huang YC, Chen GY, Xin HB, Deng KY
Cellular and molecular gastroenterology and hepatology 2024;17(6):965-981

LLLT accelerates experimental wound healing under microgravity conditions via PI3K/AKT-CCR2 signal axis.

Ye R, He Y, Ni W, Zhang Y, Zhu Y, Cao M, He R, Yao M
Frontiers in bioengineering and biotechnology 2024;12:1387474

Dual-Engineered Macrophage-Microbe Encapsulation for Metastasis Immunotherapy.

Wu L, Qiao L, Zhang S, Qiu J, Du Z, Sun Y, Chang X, Li L, Li C, Qiao X, Yin X, Hua Z
Advanced materials (Deerfield Beach, Fla.) 2024 Sep;36(36):e2406140

Decreased Proteasomal Function Exacerbates Endoplasmic Reticulum Stress-Induced Chronic Inflammation in Obese Adipose Tissue.

Nakagawa S, Fukui-Miyazaki A, Yoshida T, Ishii Y, Murata E, Taniguchi K, Ishizu A, Kasahara M, Tomaru U
The American journal of pathology 2024 Jun;194(6):1033-1046

Effects of Pain Relief Through Minimal Exercise Intervention in a Rat Model of Neuropathic Pain.

Sumizono M, Yoshizato Y, Imai T, Tani A, Nakanishi K, Nojima N, Kakimoto S, Sakakima H
Cureus 2024 Jun;16(6):e62897

Camouflaging attenuated Salmonella by cryo-shocked macrophages for tumor-targeted therapy.

Wu L, Du Z, Li L, Qiao L, Zhang S, Yin X, Chang X, Li C, Hua Z
Signal transduction and targeted therapy 2024 Jan 10;9(1):14

M2 Macrophage Membrane-Camouflaged Fe(3) O(4) -Cy7 Nanoparticles with Reduced Immunogenicity for Targeted NIR/MR Imaging of Atherosclerosis.

Zou L, Zhang Y, Cheraga N, Abodunrin OD, Qu KY, Qiao L, Ma YQ, Hang Y, Huang NP, Chen LJ
Small (Weinheim an der Bergstrasse, Germany) 2024 Feb;20(8):e2304110

Integrated-omics profiling unveils the disparities of host defense to ECM scaffolds during wound healing in aged individuals.

Chen SD, Chu CY, Wang CB, Yang Y, Xu ZY, Qu YL, Man Y
Biomaterials 2024 Dec;311:122685

Ferumoxytol-enhanced MRI assessment of venous Thrombus resolution and macrophage content in a murine deep vein thrombosis model.

Morrison L, Smoody B, Woltjer R, Hinds MT, Loftis JM, Wyatt CW, Nguyen KP
Thrombosis research 2024 Aug;240:109063

Hypoxia-induced CCL2/CCR2 axis in adipose-derived stem cells (ADSCs) promotes angiogenesis by human dermal microvascular endothelial cells (HDMECs) in flap tissues.

Fang B, Wang X, Sun Y, Xiong X, Meng X, Li W, Yi Z
Journal of physiology and biochemistry 2023 May;79(2):327-339

Single-cell RNA sequencing analysis of the temporomandibular joint condyle in 3 and 4-month-old human embryos.

Zhu Q, Tan M, Wang C, Chen Y, Wang C, Zhang J, Gu Y, Guo Y, Han J, Li L, Jiang R, Fan X, Xie H, Wang L, Gu Z, Liu D, Shi J, Feng X
Cell & bioscience 2023 Jul 19;13(1):130

Combination therapy with bevacizumab and a CCR2 inhibitor for human ovarian cancer: An in vivo validation study.

Zhai T, Mitamura T, Wang L, Kubota SI, Murakami M, Tanaka S, Watari H
Cancer medicine 2023 Apr;12(8):9697-9708

CCL2 activates AKT signaling to promote glycolysis and chemoresistance in glioma cells.

Qian Y, Ding P, Xu J, Nie X, Lu B
Cell biology international 2022 May;46(5):819-828

Targeting CCL2-CCR4 axis suppress cell migration of head and neck squamous cell carcinoma.

Ling Z, Li W, Hu J, Li Y, Deng M, Zhang S, Ren X, Wu T, Xia J, Cheng B, Tao X
Cell death & disease 2022 Feb 17;13(2):158

Identification of potential regulating effect of baicalin on NFκB/CCL2/CCR2 signaling pathway in rats with cerebral ischemia by antibody-based array and bioinformatics analysis.

Xu T, Wang X, Ma C, Ji J, Xu W, Shao Q, Liao X, Li Y, Cheng F, Wang Q
Journal of ethnopharmacology 2022 Feb 10;284:114773

Eplerenone inhibits the macrophage-to-myofibroblast transition in rats with UUO-induced type 4 cardiorenal syndrome through the MR/CTGF pathway.

Han Y, Xian Y, Gao X, Qiang P, Hao J, Yang F, Shimosawa T, Chang Y, Xu Q
International immunopharmacology 2022 Dec;113(Pt A):109396

QKI deficiency in macrophages protects mice against JEV infection by regulating cell migration and antiviral response.

Deng L, Wang W, Bian P, Wu M, Wang L, Lei Y, Lu Z, Zhai D
Molecular immunology 2022 Aug;148:34-44

ZC3H4 regulates infiltrating monocytes, attenuating pulmonary fibrosis through IL-10.

Liu Y, Zhang X, Wang J, Yang F, Luo W, Huang J, Chen M, Wang S, Li C, Zhang W, Chao J
Respiratory research 2022 Aug 12;23(1):204

Matrix metalloproteinase 11 (MMP11) in macrophages promotes the migration of HER2-positive breast cancer cells and monocyte recruitment through CCL2-CCR2 signaling.

Kang SU, Cho SY, Jeong H, Han J, Chae HY, Yang H, Sung CO, Choi YL, Shin YK, Kwon MJ
Laboratory investigation; a journal of technical methods and pathology 2022 Apr;102(4):376-390

Curcumin alleviates inflammation in Takayasu's arteritis by blocking CCL2 overexpression in adventitial fibroblasts.

Wu S, Kong X, Wang Y, Fan X, Huang Q, Chen R, Yu W, Ma L, Sun Y, Jiang L
Clinical and experimental rheumatology 2021 Mar-Apr;39 Suppl 129(2):161-170

CCL2-CCR2 Axis Potentiates NMDA Receptor Signaling to Aggravate Neuropathic Pain Induced by Brachial Plexus Avulsion.

Xian H, Jiang Y, Zhang H, Ma SB, Zhao R, Cong R
Neuroscience 2020 Jan 15;425:29-38

CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway.

Yasui H, Kajiyama H, Tamauchi S, Suzuki S, Peng Y, Yoshikawa N, Sugiyama M, Nakamura K, Kikkawa F
Clinical & experimental metastasis 2020 Feb;37(1):145-158

CCL2/CCR2 axis induces hepatocellular carcinoma invasion and epithelial-mesenchymal transition in vitro through activation of the Hedgehog pathway.

Zhuang H, Cao G, Kou C, Liu T
Oncology reports 2018 Jan;39(1):21-30

No comments: Submit comment

Supportive validation

Submitted by: Proteintech Group (provider)
Main image
Experimental details: Jurkat cells were subjected to SDS PAGE followed by western blot with 16153-1-AP(CCR2a-specific antibody) at dilution of 1:200
Sample type: cell line

Supportive validation

Submitted by: Proteintech Group (provider)
Main image
Experimental details: The CCR2-specific antibody from Proteintech is a rabbit polyclonal antibody to a peptide of human CCR2-specific. This antibody recognizes human antigen. The CCR2-specific antibody has been validated for the following applications: ELISA, WB, IHC analysis.
Appendix: 16153-1-AP.pdf

: Show more